Pre- or post-ischemic bilirubin ditaurate treatment reduces oxidative tissue damage and improves cardiac function

International Journal of Cardiology

Volumn 202, Issue , 2016, Pages 27-33

  Bakrania, Bhavisha ^a   Du Toit, Eugene F ^a   Wagner, Karl Heinz ^a,b   Headrick, John P ^a   Bulmer, Andrew C ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antioxidant; Gilbert's syndrome; Heme oxygenase; Myocardial ischemia reperfusion; Oxidative stress

Indexed keywords

BILIRUBIN DERIVATIVE; BILIRUBIN DITAURATE; CARBONYL DERIVATIVE; CREATINE KINASE; MALONALDEHYDE; UNCLASSIFIED DRUG; BILIRUBIN; BILIRUBIN DITAURINE; TAURINE;

ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; DIASTOLE; EX VIVO STUDY; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART PERFUSION; HEART PROTECTION; HEART VENTRICLE PRESSURE; ISCHEMIA; ISOLATED HEART; LIPID OXIDATION; MALE; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TISSUE INJURY; ANALOGS AND DERIVATIVES; ANIMAL; CARDIAC MUSCLE; COMPLICATION; CORONARY ARTERY BLOOD FLOW; DISEASE MODEL; DRUG EFFECTS; GILBERT DISEASE; HEART ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART VENTRICLE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; BILIRUBIN; CORONARY CIRCULATION; CREATINE KINASE; DISEASE MODELS, ANIMAL; GILBERT DISEASE; HEART ATRIA; HEART RATE; HEART VENTRICLES; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; RATS, WISTAR; TAURINE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 84959527688     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.08.192     Document Type: Article

References (41)

1. P. Maroko, J. Kjekshus, B. Sobel, T. Watanabe, J. Covell, J.J. Ross, and et al. Factors influencing infarct size following experimental coronary artery occlusions Circulation 43 1971 67 82
2. G. Heusch Cardioprotection: chances and challenges of its translation to the clinic Lancet 381 2013 166 175
3. P. Ferdinandy, R. Schulz, and G. Baxter Interaction of cardiovascular risk factors with myocardial ischaemia/reperfusion injury, preconditioning, and postconditioning Pharmacol. Rev. 59 2007 418 458
4. J.N. Peart, and J.P. Headrick Clinical cardioprotection and the value of conditioning responses Am. J. Physiol. Heart Circ. Physiol. 296 2009 H1705 H1720
5. A.C. Bulmer, J.C. Coombes, J.T. Blanchfield, I. Toth, R. Fassett, and S.M. Taylor Bile pigment pharmacokinetics and absorption in the rat: therapeutic potential for enteral administration Br. J. Pharmacol. 164 2011 1857 1870
6. M. Wallner, A.C. Bulmer, C. Mölzer, E. Müllner, R. Marculescu, D. Doberer, and et al. Haem catabolism: a novel modulator of inflammation in Gilbert's syndrome Eur. J. Clin. Investig. 43 2013 912 919
7. A.C. Bulmer, H.J. Verkade, and K.-H. Wagner Bilirubin and beyond: a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection Prog. Lipid Res. 52 2013 193 205
8. C.P. Strassburg Pharmagenetics of Gilbert's Syndrome Pharmacogenomics 2008 703 715
9. A.-C. Boon, C.L. Hawkins, K. Bisht, J.S. Coombes, B. Bakrania, K.-H. Wagner, and et al. Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome Free Radic. Biol. Med. 52 2012 2120 2127
10. A.-C. Boon, A.C. Bulmer, J.S. Coombes, and R.G. Fassett Circulating bilirubin and defense against kidney disease and cardiovascular mortality: mechanisms contributing to protection in clinical investigations Am. J. Physiol. Ren. Physiol. 307 2014 F123 F136
11. B. Bakrania, E.F. Du Toit, K.J. Ashton, C.J. Kiessling, K.-H. Wagner, J.P. Headrick, and et al. Hyperbilirubinemia modulates myocardial function, aortic ejection, and ischemic stress resistance in the Gunn rat Am. J. Physiol. Heart Circ. Physiol. 307 2014 H1142 H1149
12. K. Bisht, J. Tampe, C. Shing, B. Bakrania, J. Winearls, J. Fraser, and et al. Endogenous tetrapyrroles influence leukocyte responses to lipopolysaccharide in human blood: pre-clinical evidence demonstrating the anti-inflammatory potential of biliverdin J. Clin. Cell. Immunol. 5 2014 1000218
13. L.J. Horsfall, I. Nazareth, S.P. Pereira, and I. Peterson Gilbert's syndrome and the risk of death: a population-based cohort study J. Gastroenterol. Hepatol. 28 2013 1643 1647
14. A.-L. Levonen, E. Vähäkangas, J.K. Koponen, and S. Ylä-Herttuala Antioxidant gene therapy for cardiovascular disease: current status and future perspectives Circulation 117 2008 2142 2150
15. Y. Issan, R. Kornowski, D. Aravot, A. Shainberg, M. Laniado-Schwartzman, K. Sodhi, and et al. Heme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stress PLoS One 9 2014 e92246
16. C. Zhou, H. Li, Y. Yao, and L. Li Delayed remote ischemic preconditioning produces an additive cardioprotection to sevoflurane postconditioning through an enhanced heme oxygenase 1 level partly via nuclear factor erythroid 2-related factor 2 nuclear translocation J. Cardiovasc. Pharmacol. Ther. 19 2014 558 566
17. C. Zhou, L. Li, H. Li, J. Gong, and N. Fang Delayed remote preconditioning induces cardioprotection: role of heme oxygenase-1 J. Surg. Res. 191 2014 51 57
18. R. Lu, J. Peng, L. Xiao, H. Deng, and Y. Li Heme oxygenase-1 pathway is involved in delayed protection induced by heat stress against cardiac ischemia-reperfusion injury Int. J. Cardiol. 82 2002 130 144
19. C. Adin, B.P. Croker, and A. Agarwal Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney Am. J. Physiol. Ren. Physiol. 288 2005 F778 F784
20. C. Ceran, K. Sonmez, Z. Turkyilmaz, B. Demirogullari, A. Dursun, E. Duzgun, and et al. Effect of bilirubin in ischemia/reperfusion injury on rat small intestine J. Pediatr. Surg. 36 2001 1764 1767
21. C. Hammerman, D. Goldschmidt, M. Caplan, M. Kaplan, R. Bromiker, A. Eidelman, and et al. Protective effect of bilirubin in ischemia-reperfusion injury in the rat intestine J. Pediatr. Gastroenterol. Nutr. 35 2002 344 349
22. K. Koschutnig, S. Heikkinen, S. Kemmo, A. Lampi, V. Piironen, and K.-H. Wagner Cytotoxic and apoptotic effects of single and mixed oxides of beta-sitosterol on HepG2-cells Toxicol. In Vitro 23 2009 755 762
23. C. Mölzer, H. Huber, A. Steyrer, G. Ziesel, A. Ertl, A. Plavotic, and et al. In vitro antioxidant capacity and antigenotoxic properties of protoporphyrin and structurally related tetrapyrroles Free Radic. Res. 46 2012 1369 1377
24. A. Bulmer, K. Ried, J. Blanchfield, and K.-H. Wagner The anti-mutagenic properties of bile pigments Mutat. Res. 658 2008 28 41
25. R. Stocker Antioxidant activities of bile pigments Antioxid. Redox Signal. 2004 841 849
26. R. Stocker, Y. Yamamoto, A.F. McDonagh, A.N. Glazer, and B.N. Ames Bilirubin is an antioxidant of possible physiological importance Science 235 1987 1043 1046
27. A.C. Carr, B. Zhu, and B. Frei Potential antiatherogenic mechanisms of ascorbate (vitamin c) and alpha-tocopherol (vitamin E) Circ. Res. 87 2000 349 354
28. L.J. Hazell, and R. Stocker Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages Biochem. J. 172 1993 165 172
29. R. Ben-Amotz, J. Bonagura, M. Velayutham, R. Hamlin, P. Burns, and C. Adin Intraperitoneal bilirubin administration decreases infarct area in a rat coronary ischemia/reperfusion model Front. Physiol. 5 2014 53
30. J.E. Clark, R. Foresti, P. Sarathchandra, H. Kaur, C.J. Green, and R. Motterlini Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction Am. J. Physiol. Heart Circ. Physiol. 278 2000 H643 H651
31. E. Masini, A. Vannacci, C. Marzocca, S. Pierpaoli, L. Giannini, O. Fantappie, and et al. Heme oxygenase-1 and the ischemia-reperfusion injury in the rat heart Exp. Biol. Med. (Maywood) 228 2003 546 549
32. S. Verma, P. Fedak, R. Weisel, J. Butany, V. Rao, A. Maitland, and et al. Fundamentals of reperfusion injury for the clinical cardiologist Circulation 105 2002 2332 2336
33. G.L. Mazzone, I. Rigato, and C. Tiribelli Unconjugated bilirubin modulates nitric oxide production via iNOS regulation Biosci. Trends 4 2010 244 248
34. S.L. Nuttall, M.J. Kendall, and U. Martin Antioxidant therapy for the prevention of cardiovascular disease Q. J. Med. 92 1999 239 244
35. S.P. Jones, X.-L. Tang, Y. Guo, C. Steenbergen, D.J. Lefer, R.C. Kukreja, and et al. The NHLBI-sponsored consortium for preclinicAl assESsment of cARdioprotective Therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs Circ. Res. 116 2015 572 586
36. P.Z. Gerczuk, and R.A. Kloner An update on cardioprotection: a review of the latest adjunctive therapies to limit myocardial infarction size in clinical trials J. Am. Coll. Cardiol. 59 2012 969 978
37. D.J. Lefer, and R. Bolli Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation J. Cardiovasc. Pharmacol. Ther. 16 2011 332 339
38. Y.-H. Chen, S.-C. Hung, and D.-C. Tarng Serum bilirubin links UGT1A1∗28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients Clin. J. Am. Soc. Nephrol. 6 2011 567 574
39. L. McCallum, J. Panniyammakal, C.E. Hastie, J. Hewitt, R. Patel, G.C. Jones, and et al. Longitudinal blood pressure control, long-term mortality, and predictive utility of serum liver enzymes and bilirubin in hypertensive patients Hypertension 66 2015 37 43
40. L.J. Horsfall, G. Rait, K. Walters, D. Swallow, S.P. Pereira, I. Nazareth, and et al. Serum bilirubin and risk of respiratory disease and death JAMA 16 2011 691 697
41. K.-H. Wagner, M. Wallner, C. Mölzer, S. Gazzin, A.C. Bulmer, C. Tiribelli, and et al. Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases Clin. Sci. 129 2015 1 25